Efficacy
Tumor
TUMOR
In cohort A and cohort B, ORR was 35.5% (95% CI: 19.2, 54.6) and 35.7% (95% CI; 18.6, 55.9), and median DoR was 13.6 months (95% CI: 4.14, NE) and 13.67 months (95% CI: 3.52, NE), respectively (Tumor response by investigator review per RECIST v1.1.Percentage of best response for target lesion from baseline.The median PFS was 9.7 months (95% CI: 6.9, 11.7 ) in total population (Kaplan–Meier curves of PFS: 